Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Damora Therapeutics, Inc.

DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001800315

In the last 90 days, Damora Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.

Holders of 5% or more of DMRA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Damora Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of DMRA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Fairmount Funds Management LLC13D/A19.99%8.71M shares0.00 ppfrom 19.99%Nov 17, 20252 filingsFeb 11, 2026SEC
FMR LLC13G15.00%238.9K sharesNewDec 5, 20251 filingDec 5, 2025SEC
Avoro Capital Advisors LLC13G6.27%3.78M sharesNewMay 15, 20261 filingMay 15, 2026SEC
Venrock Healthcare Capital Partners III, L.P.13G6.00%3.60M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
BlackRock, Inc.13G5.10%3.14M sharesNewJul 28, 20261 filingJul 28, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

40 Schedule 13D and 13G filings on Damora Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DMRA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 28, 20264:44 PM ETBlackRock, Inc.13G5.10%3.14M sharesNewJun 30, 2026SEC
May 15, 20264:20 PM ETPoint72 Asset Management, L.P.and 2 others13G/A2.00%1.19M shares−4.30 ppfrom 6.30%Below 5%Mar 31, 2026SEC
May 15, 20264:16 PM ETJain Global LLCand 2 others13G/A0.00%0 shares−7.50 ppfrom 7.50%Below 5%Mar 31, 2026SEC
May 15, 20268:16 AM ETAvoro Capital Advisors LLCand 1 other13G6.27%3.78M sharesNewMar 31, 2026SEC
Apr 23, 20269:22 PM ETParamora Holding LLC13G/A3.39%2.05M shares−4.11 ppfrom 7.50%Below 5%Feb 9, 2026SEC
Apr 23, 20269:19 PM ETParagon Therapeutics, Inc.13G/A3.39%2.05M shares−4.11 ppfrom 7.50%Below 5%Feb 9, 2026SEC
Mar 6, 20264:43 PM ETIkarian Capital, LLCand 1 other13G/A0.60%335.7K shares−20.90 ppfrom 21.50%Below 5%Feb 28, 2026SEC
Feb 17, 20267:17 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G6.00%3.60M sharesNewFeb 9, 2026SEC
Feb 17, 20264:35 PM ETJain Global LLCand 2 others13G7.50%120.6K sharesNewDec 31, 2025SEC
Feb 11, 20266:11 PM ETFairmount Funds Management LLCand 4 others13D/A19.99%8.71M shares0.00 ppfrom 19.99%Feb 9, 2026SEC
Jan 12, 20264:06 PM ETParamora Holding LLC13G7.50%120.5K sharesNewNov 10, 2025SEC
Jan 12, 20264:01 PM ETParagon Therapeutics, Inc.13G7.50%120.5K sharesNewNov 10, 2025SEC
Dec 5, 20254:50 PM ETIkarian Capital, LLCand 1 other13G21.50%285.7K sharesNewNov 30, 2025SEC
Dec 5, 20251:50 PM ETFMR LLCand 1 other13G15.00%238.9K sharesNewNov 28, 2025SEC
Nov 17, 20259:45 PM ETFairmount Funds Management LLCand 4 others13D19.99%397.0K sharesNewNov 10, 2025SEC
Nov 13, 20255:26 PM ETPoint72 Asset Management, L.P.and 2 others13G6.30%100.0K sharesNewNov 12, 2025SEC
Oct 9, 20254:29 PM ETNovo Holdings A/S13D/A0.00%0 shares−6.50 ppfrom 6.50%Below 5%Oct 7, 2025SEC
Sep 25, 20254:49 PM ETNovo Holdings A/S13D/A6.50%86.6K shares−1.10 ppfrom 7.60%Sep 23, 2025SEC
Jan 16, 20259:43 PM ETNovo Holdings A/S13D/A7.60%99.9K shares–Aug 29, 2024SEC
Nov 7, 2024Sunstone Life Science Ventures A/S13G/AOld format–––SEC
Nov 7, 2024Sunstone Life Science Ventures A/S13GOld format–New–SEC
Aug 29, 2024Otto Erik13G/AOld format–––SEC
Jun 24, 2024Novo Holdings A/S13D/AOld format–––SEC
Feb 9, 20243:06 PM ETOtto Erik13G/A7.60%2.06M shares–Dec 31, 2023SEC
Oct 3, 2023Otto Erik13GOld format–New–SEC
Sep 18, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Sep 5, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Aug 17, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Aug 2, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Jul 17, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Apr 7, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Sep 30, 2022Novo Holdings A/S13D/AOld format–––SEC
Feb 14, 2022Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 11, 2022HBM Healthcare Investments (Cayman) Ltd.13G/AOld format–––SEC
Feb 10, 2022Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2022Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Feb 16, 2021Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 12, 2021Janus Henderson Group PLC13GOld format–New–SEC
Feb 12, 2021Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Feb 12, 2021HBM Healthcare Investments (Cayman) Ltd.13GOld format–New–SEC

Form 144: proposed insider sales

38 notices from officers, directors and other affiliates planning to sell Damora Therapeutics, Inc. shares, newest first.

Form 144 notices for DMRA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 6, 202611:34 AM ETFirmani LoriOfficer1.80K$56.0KAug 5, 2026Maxim GroupSEC
Jun 22, 20262:27 PM ETFirmani LoriOfficer7.62K$193.1KJun 22, 2026Maxim GroupSEC
Oct 2, 20239:55 PM ETThe Biotech Growth Trust PLCShareholder57.3K$41.3KOct 2, 2023Merrill Lynch, Pierce, Fenner & Smith IncorporatedSEC
Oct 2, 20239:53 PM ETOrbiMed Israel Partners II, L.P.Shareholder244.5K$176.1KOct 2, 2023Merrill Lynch, Pierce, Fenner & Smith IncorporatedSEC
Oct 2, 20239:50 PM ETOrbiMed Genesis Master Fund, L.P.Shareholder37.7K$27.1KOct 2, 2023Merrill Lynch, Pierce, Fenner & Smith IncorporatedSEC
Oct 2, 20239:49 PM ETOrbiMed Private Investments VII, LPShareholder585.3K$421.4KOct 2, 2023Merrill Lynch, Pierce, Fenner & Smith IncorporatedSEC
Aug 30, 20235:17 PM ETThe Biotech Growth Trust PLCShareholder119.7K$69.4KAug 30, 2023Bank of AmericaSEC
Aug 30, 20235:08 PM ETOrbiMed Israel Partners II, L.P.Shareholder510.6K$296.2KAug 30, 2023Bank of AmericaSEC
Aug 30, 20235:02 PM ETOrbiMed Genesis Master Fund, L.P.Shareholder78.7K$45.6KAug 30, 2023Bank of AmericaSEC
Aug 30, 20234:56 PM ETOrbiMed Private Investments VII, LPShareholder1.22M$708.8KAug 30, 2023Bank of AmericaSEC
Aug 21, 20238:14 PM ETAmendedOrbiMed Genesis Master Fund, L.P.Shareholder97.2K$60.0KAug 21, 2023Bank of AmericaSEC
Aug 21, 20234:57 PM ETOrbiMed Private Investments VII, LPShareholder1.51M$931.9KAug 21, 2023Bank of AmericaSEC
Aug 21, 20234:47 PM ETThe Biotech Growth Trust PLCShareholder147.9K$91.3KAug 21, 2023Bank of AmericaSEC
Aug 21, 20234:39 PM ETOrbiMed Israel Partners II, L.P.Shareholder631.0K$389.4KAug 21, 2023Bank of AmericaSEC
Aug 15, 20236:29 PM ETThe Biotech Growth Trust PLCShareholder114.8K$86.1KAug 15, 2023Bank of AmericaSEC
Aug 15, 20236:25 PM ETOrbiMed Israel Partners II, L.P.Shareholder490.0K$367.5KAug 15, 2023Bank of AmericaSEC
Aug 15, 20236:22 PM ETOrbiMed Private Investments VII, LPShareholder1.17M$879.5KAug 15, 2023Bank of AmericaSEC
Aug 15, 20236:19 PM ETOrbiMed Genesis Master Fund, L.P.Shareholder75.5K$56.6KAug 15, 2023Bank of AmericaSEC
Jul 31, 20236:38 PM ETThe Biotech Growth Trust PLCShareholder246.8K$745.4KJul 31, 2023Bank of AmericaSEC
Jul 31, 20236:36 PM ETOrbiMed Israel Partners II, L.P.Shareholder180.3K$544.5KJul 31, 2023Bank of AmericaSEC
Jul 31, 20236:31 PM ETOrbiMed Private Investments VII, LPShareholder930.7K$2.81MJul 31, 2023Bank of AmericaSEC
Jul 31, 20236:29 PM ETOrbiMed Genesis Master Fund, L.P.Shareholder162.2K$489.7KJul 31, 2023Bank of AmericaSEC
Jul 25, 20235:00 PM ETThe Biotech Growth Trust PLCShareholder8.10K$19.0KJul 25, 2023Bank of AmericaSEC
Jul 25, 20234:57 PM ETOrbiMed Israel Partners II, L.P.Shareholder4.70K$11.0KJul 25, 2023Bank of AmericaSEC
Jul 25, 20234:54 PM ETOrbiMed Private Investments VII, LPShareholder26.7K$62.7KJul 25, 2023Bank of AmericaSEC

Showing the latest 25. See the DMRA notices from the last 12 months